The beverage opportunity is particularly strong because of what GLP-1 users actually need: these medications lower food intake and stimulate electrolyte excretion through the kidneys, users face specific risks of cramping, fatigue, and dehydration, said John Scheer, co-founder and Chief Creative Officer of healthcare and wellbeing branding agency Herman Scheer So its not just about marketing: its about genuine functional demand. GLP-1 friendly products While electrolytes are the key element of the hydration proposition, drinks need to go beyond that
For those seeking FDA-approved treatments, immediate medical intervention, or guaranteed outcomes, conventional medical care remains the appropriate path
Which tests help evaluate toxic overload and depression
The FDA cited three deaths among patients who took the medications, including one who died by suicide, saying the company did not report them within the agencys required time frame
Like many protein-based medicines, tirzepatide can lose strength and stability when it gets too warm
After all, who wouldnt want to heal like a superhero